Cargando…
Long non‐coding RNA ZEB2‐AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple‐negative breast cancer by epigenetically activating ZEB2
The triple‐negative breast cancer is the most malignant type of breast cancer. Its pathogenesis and prognosis remain poor despite the significant advances in breast cancer diagnosis and therapy. Meanwhile, long noncoding RNAs (LncRNAs) play a pivotal role in the progression of malignant tumors. In t...
Autores principales: | Zhang, Guoxin, Li, Hongli, Sun, Ruimei, Li, Peirui, Yang, Zhiyi, Liu, Yuanyuan, Wang, Zhaoyan, Yang, Yuling, Yin, Chonggao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484319/ https://www.ncbi.nlm.nih.gov/pubmed/30825262 http://dx.doi.org/10.1111/jcmm.14213 |
Ejemplares similares
-
Overexpression of ZEB2‐AS1 promotes epithelial‐to‐mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma
por: Diao, Pengfei, et al.
Publicado: (2019) -
Microarray expression profile of long non‐coding RNAs in human lung adenocarcinoma
por: Yang, Zhiyi, et al.
Publicado: (2018) -
miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
por: GUO, FEI, et al.
Publicado: (2014) -
MiR-486-5p inhibits IL-22-induced epithelial-mesenchymal transition of breast cancer cell by repressing Dock1
por: Li, Hongli, et al.
Publicado: (2019) -
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
por: Kim, Taewan, et al.
Publicado: (2011)